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~bstract 13H]Thymidine (TdR) incorporation by human osteo- 
~arcoma cell line MG-63 was significantly stimulated at as early 
as 3 h after the addition of either TIMP-1 or TIMP-2 alone. 
Maximum stimulation was attained at a concentration of either 
20 nglml (0.71 nM) TIMP-I or 1.0 ng/ml (46 pM) TIMP-2. 
ryrosine kinase inhibitors such as genistein, erbstatin, and 
herbimycin A almost completely inhibited the [3HITdR incor- 
poration stimulated by either of the TIMPs. However, essentially 
no effect was observed with H-89, H-7, bisindolylmaleimide and 
K-252a. These inhibition studies suggest a crucial role for 
t yrosine kinase in the signal transduction of TIMPs. Phospho- 
lyrosine-containing proteins were significantly elevated by the 
treatment with both TIMPs. We also found that either TIMP 
~timulated an increase in mitogen-activated protein (MAP) 
kinase activity, suggesting that MAP kinase plays a role in 
rlMP-dependent growth signaling. 
~ey words: Tissue inhibitor of metalloproteinase; C ll 
;rowth factor; Tyrosine kinase; Mitogen-activated protein 
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I. Introduction 
Tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2, 
md TIMP-3) are now recognized as a family of intrinsic 
:ommon inhibitors of matrix metalloproteinases (MMPs) re- 
:)resented by interstitial collagenase, and both TIMP-1 and 
rlMP-2 also inhibit the autoactivation step of progelatinase 
tctivation by forming complexes with progelatinases in a 1:1 
aoichiometry [1,2]. It therefore seems that TIMPs play an 
mportant role in the regulation of MMP activity under 
9oth physiological nd pathological conditions. 
In addition to their functions as MMP inhibitors, both 
FIMP-1 and TIMP-2 are reported to have potent growth- 
9romoting activity for a wide range of cells, and some findings 
rapport he proposition that both TIMPs are previously un- 
-ecognized cell-growth factors in serum [3,4]. The cell growth- 
3romoting activity of both TIMPs appears to be a direct 
~ellular effect mediated by cell-surface receptors [4-6], and is 
ndependent of their functions as MMP inhibitors. While 
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growth signaling by a wide range of growth factors depends 
on tyrosine phosphorylation f cellular proteins and some of 
these factors activate the mitogen-activated protein (MAP) 
kinases [7,8], recent papers uggest that members of the Janus 
kinase (JAK) family activate signal transducers and activators 
of transcription (STATs) that are directly involved in the reg- 
ulation of gene transcription [9,10]. Thus, it has yet to be 
elucidated whether tyrosine kinase and its downstream-signal- 
ing factors are involved in growth stimulation by TIMPs. 
In this study, we report that the stimulation of DNA syn- 
thesis by either TIMP-1 or TIMP-2 is mediated through tyro- 
sine phosphorylation following the activation of MAP kinase. 
2. Materials and methods 
2.1. Materials 
The materials used and their sources were as follows: [methyl- 
3H]thymidine ([3H]TdR) from Amersham International plc (Bucks, 
UK); [7-32plATP (370 MBq/ml) from Dupont NEN (DE, USA); 
myelin basic protein (MBP) of bovine brain from Sigma Chemical 
Co. (MO, USA); genistein from Extrasynthese S.A. (Genay, France); 
erbstatin from Research Biochemicals International (MA, USA); her- 
bimycin A from Kyowa Medex Co. (Tokyo, Japan); H-89, H-7 and 
K-252a from Biomol Research Laboratories, Inc. (PA, USA); Dul- 
becco's modified Eagle's minimal essential medium (D-MEM) and 
fetal calf serum (FCS) from Gibco Laboratories (Grand Island, 
NY); anti-extracellular-signal-regulated proteinkinase 2 (ERK2) anti- 
body from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA); and 
human osteosarcoma cells (MG-63, CRL 1427) from the American 
Type Culture Collection (Rockville, MD). TIMP-1- and TIMP-2-free 
FCS was prepared as previously described [4]. Anti-phosphotyrosine 
(PTYR) polyclonal antibody was purchased from ICN Biomedicals. 
Inc. (CA, USA). 
2.2. Preparation of human TIMPs and their assays 
Human recombinant TIMP-1 and TIMP-2 were prepared as re- 
ported previously [4]. TIMP-1 and TIMP-2 concentrations were de- 
termined by one-step sandwich enzyme immunoassays for TIMP-1 
[11] and TIMP-2 [12]. 
2.3. [3 H]TdR incorporation assay 
Cells were plated into 24-well plastic plates at 1 × 105 cells/well and 
then allowed to grow to confluence in 1 ml of D-MEM containing 
10% FCS. The confluent cultures were then shifted to serum-free D-
MEM for 48 h before the assay. The cells were incubated inD-MEM 
containing TIMP-I or TIMP-2 for the indicated times, and incubation 
was extended for a further 5 h after the addition of 0.8 ~tCi/ml 
[3H]TdR solution. The cultures were then washed three times with 1 
ml of ice-cold phosphate-buffered saline. After having been left in ice- 
cold 5% trichloroacetic a id for 20 min, the precipitates were washed 
twice with 1 ml of the same trichloroacetic a id solution. The precip- 
itates were subsequently solubilized with 0.5 M NaOH and [aH]TdR 
incorporated was determined by use of a liquid scintillation spectro- 
meter with 40% counting efficiency. 
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2.4. Immunoblotting 
Confluent cells were starved for 24 h in D-MEM, subsequently 
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Fig. 1. Effects of preincubation time on TIMP-dependent [3H]TdR 
incorporation by human osteosarcoma cell line MG-63. MG-63 cells 
grown to confluence were incubated in D-MEM containing either 
20 ng/ml TIMP-1 or 1.0 ngJml TIMP-2 for the indicated times. The 
incubation was extended for a further 5 h after the addition of 0.8 
/aCi/ml [3H]TdR. [3H]TdR incorporated into the cells was deter- 
mined as described in Section 2. All the values with TIMP-I (O) 
and TIMP-2 (0) are shown as net values after subtracting the corre- 
sponding control (D-MEM alone) value (z~). *p < 0.05 from time 0. 
<-_ 
treated with acidic medium for 3 min [13], and then incubated for 
another 10 min in D-MEM. Finally, the cells were stimulated with 20 
ng/ml TIMP-1 or 1.0 ng/ml TIMP-2 for the indicated times. Then the 
cells were washed with ice-cold phosphate-buffered saline containing 
1.0 mM sodium orthovanadate, and quickly solubilized with buffer 
for gel electrophoresis containing 2% sodium dodecyl sulfate and 5% 
mercaptoethanol. The protein concentration was determined with a 
protein assay kit (Bio-Rad Laboratories), and 100 gg of proteins was 
subjected to sodium dodecyl sulfate polyacrylamide g l electrophoresis 
(SDS-PAGE). After electrophoresis, the proteins were transferred 
electrophoretieally to polyvinylidene difluoride membranes (Milli- 
pore), probed with anti-PTYR antibody or anti-ERK2 antibody, 
and subsequently incubated with peroxidase-conjugated protein A 
(Amersham). Tyrosine-phosphorylated proteins or ERK2 was de- 
tected by an ECL system (Amersham). After transfer of the proteins 
from gels to membranes, the gels were stained with Coomassie blue to 
confirm the application of the proper amounts of proteins to the gels. 
2.5. Assay for MAP kinase activity 
This assay was performed using polyacrylamide gels containing 
MBP after SDS-PAGE according to a modified method [14] of Ka- 
meshita nd Fujisawa [15]. Essentially the same procedure as men- 
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Fig. 2. Effects of addition of different concentrations of TIMP-1 and TIMP-2 (A) and depletion of both TIMPs from 10% FCS (B) on 
[3H]TdR incorporation by MG-63 cells. MG-63 cells grown to confluence were incubated for 20 h in D-MEM containing the indicated 
amounts of either TIMP. The incubation was extended for a further 5 h after the addition of 0.8 p, Ci/ml [3H]TdR. [aH]TdR incorporated into 
the cells was determined as described in Section 2. *TIMP ( - )  FCS denotes 10% FCS freed of both TIMP-I and TIMP-2. **The amounts of 
rTIMP-1 and -2 added were 38 and 32 ng/ml, respectively, which were the same as those originally contained in 10% FCS. 
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Fig. 3. Effects of protein kinase inhibitors on [3H]TdR incorporation i to MG-63 cells stimulated by both TIMPs. MG-63 cells having reached 
:onfluence were incubated for 16 h in D-MEM containing either of the TIMPs without or with inhibitors of the indicated concentrations. The 
ncubation was extended for 5 h after the addition of 0.8 p.Ci/ml [3H]TdR. Incorporation of radiolabel into the cells was determined as de- 
scribed in Section 2. *p < 0.005 and *'p < 0.02 from D-MEM alone. 
tioned above was used for the preparation of cell lysates except that 
the cells were incubated for 24 h instead of 10 min in D-MEM after 
the acid treatment prior to TIMP stimulation. 
3. Results 
We first examined the time course of TIMP-dependent 
[3H]TdR incorporation by MG-63 cells. [3H]TdR incorpora- 
tion was significantly stimulated at 3 h after the addition of 
either TIMP-1 or TIMP-2, as shown in Fig. 1, and the in- 
corporation remained linear up to 15-20 h. The effects of 
TIMPs on [3H]TdR incorporation were dose dependent, 
showing maximum stimulation at a concentration of either 
20 ng/ml TIMP-1 or 1.0 ng/ml TIMP-2 (Fig. 2A). The extent 
of stimulation with either TIMP was comparable to that ob- 
tained with 10% FCS. We also demonstrated that [3H]TdR 
incorporation i to MG-63 cells by 10% FCS was almost fully 
dependent on TIMPs in FCS (Fig. 2B). 
To gain a clue as to the nature of the intracellular signal 
transduction, we next examined the effects of some protein 
kinase inhibitors on [3H]TdR incorporation into the cells. 
As shown in Fig. 3, genistein, erbstatin and herbimycin A
almost completely inhibited the incorporation of [ZH]TdR 
stimulated by either TIMP. However, essentially no effect 
was observed with H-89, H-7, bisindolylmaleimide or K- 
252a. These inhibition studies thus suggest the possible parti- 
cipation of tyrosine kinase in the signal transduction of 
TIMPs. To confirm this possibility, we examined the tyro- 
sine-specific phosphorylation stimulated by either TIMP. As 
shown in Fig. 4A, tyrosine-specific phosphorylation in MG-63 
cells was suppressed by serum depletion and was significantly 
increased in response to the addition of either TIMP. 
When we examined the possible involvement of MAP ki- 
nases in the downstream signal transduction pathway, we 
found that both TIMPs significantly stimulated the activation 
of one of the MAP kinases, ERK2 (Fig. 4B), and the activity 
of this kinase (Fig. 4C) in MG-63 cells. 
4. Discussion 
We reported earlier that human TIMP-1 and TIMP-2 have 
potent growth-promoting activity for a wide range of cells 
[3,4]. TIMP-3, produced by chicken embryo fibroblasts, was 
also shown to have a cell growth-promoting activity [16], 
leading us to conclude that such activity is a common feature 
of members of the TIMP family. The cell growth-promoting 
activity of both TIMP-1 and -2 is suggested to be a direct 
cellular effect mediated by cell surface receptors [4-6], rather 
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Fig. 4. Increase in amount of PTYR-containing proteins (A), activa- 
tion of MAP kinase (B), and detection of the kinase activity (C) in 
MG-63 cells treated with either TIMP-1 or TIMP-2. Confluent cell 
cultures were starved in serum-depleted medium and subsequently 
stimulated with either TIMP for 10 rain. Cell lysates from MG-63 
cells were subjected to SDS/PAGE and examined by immunoblot- 
ting with anti-PTYR (A) or anti-ERK2 (B) antibody, as described 
in Section 2. The cell lysates were also electrophoresed in SDS- 
PAGE containing MBP. After renaturation of proteins in the gels, 
the kinase activity was determined (C), as described in Section 2. 1, 
D-MEM alone; 2, 1+20 ng/ml TIMP-1; 3, 1+1.0 ng/ml TIMP-2; 4, 
1+10% FCS. Activity bands corresponding to ERK2, 1~ in (C), 
were quantified by the use of an image analyzer (Fuji BAS 2000) to 
give relative values of 1.0, 3.8, 3.3, and 3.7, respectively. Open and 
solid arrowheads in (B) denote non-activated and activated, respec- 
tively. 
than being due to the inhibition of MMPs. It has also been 
demonstrated that the binding of TIMP-2 to the cell surface is 
not competed by TIMP-I, suggesting that both TIMPs have 
their own specific receptors [4,17]. 
We have further confirmed here the direct action of both 
TIMPs on the cells as cell-growth factors by showing that 
[3H]TdR incorporation was significantly stimulated at 3 h 
after the addition of either TIMP and that the incorporation 
was linear up to 15-20 h. 
The dose-response curve for either TIMP-1 or TIMP-2 
showed a bell-shape profile for [3H]TdR incorporation, which 
is consistent with TIMP-dose curves for cell proliferation [4], 
with maximum incorporation at 20 ng/ml (0.71 nM) for 
TIMP-1 and 1.0 ng/ml (46 pM) for TIMP-2 (Fig. 2A). The 
maximum response to either TIMP-1 or TIMP-2 was compar- 
able to that found with 10% FCS. 
Tyrosine kinase inhibitors, such as genistein, erbstatin, and 
herbimycin A, effectively blocked the [3H]TdR incorporation 
into MG-63 cells (Fig. 3), indicating that activation of tyro- 
sine kinase is required for the stimulation of DNA synthesis 
mediated by either TIMP-I or TIMP-2. Either genistein or 
erbstatin inhibited [3H]TdR incorporation significantly to a 
level below that in D-MEM alone, indicating that they also 
inhibited the autocrine stimulation by TIMP-I produced by 
the cells themselves during the 21 h incubation. Both TIMPs 
stimulated tyrosine-specific phosphorylation of some cellular 
proteins (,~200 and ,-~ 130 kDa, Fig. 4A). The effects of 
many growth factors, such as EGF, PDGF, insulin, and 
IGF-I, are known to be mediated by high-affinity receptor 
tyrosine kinases. Both TIMP-1 and TIMP-2 seem to be new 
ligands that may be categorized in this group, even though it 
is not yet clear what type of tyrosine kinases are involved in 
the signaling pathways induced by them [7,18]. 
MAP kinases have been characterized as ubiquitous com- 
ponents of signal transduction pathways from yeasts to verte- 
brates, and thus have been implicated in the control of a 
broad spectrum of cellular events, particularly in view of their 
roles in cell proliferation and/or differentiation [8,19]. Re- 
cently, activation of constitutive MAP kinase by MAP kinase 
kinase was shown to be necessary and sufficient for cell differ- 
entiation or proliferation depending on the cellular context 
[20]. At least four distinct MAP kinases have been purified 
and studied in depth [19,21]. In this study we demonstrated 
the activation of at least one of the group, ERK2 (Fig. 4B), 
and detected MAP kinase activity in lysates of TIMP-treated 
cells in SDS-PAGE containing MBP (Fig. 4C), suggesting that 
MAP kinase transduces TIMP-dependent growth signaling. 
During the course of this work, Corcoran and Stetler-Ste- 
venson [22] reported that TIMP-2 stimulated the proliferation 
of fibrosarcoma cells and normal dermal fibroblasts via a 
cAMP-dependent intracellular signal transduction pathway. 
In this study we showed that H-89, H-7, bisindolylmaleimide, 
and K-252a, known to be potent inhibitors of protein kinase 
A, C, and G, and myosin light chain kinase [23], had essen- 
tially no inhibitory activity on [3H]TdR incorporation into 
MG-63 cells stimulated by either TIMP (Fig. 3). One obvious 
difference between our two studies is in the TIMP-2 concen- 
tration used; i.e. they used 0.5-1 ~tg/ml TIMP-2, which is 500- 
1000-times higher than the level we used. By using Raji cells, 
which express neither TIMP-1 nor TIMP-2, we demonstrated 
the presence of both high (Ka = 0.15 nM) - and low (35 nM) - 
affinity binding sites on the cell surface [4]. Taking into ac- 
count these Ka values, we may speculate that we are looking 
at signal transduction evoked through TIMP-2 binding to 
high-affinity binding sites, whereas Corcoran and Stetler-Ste- 
venson studied another pathway involving transduction 
through low-affinity binding sites. Experiments with this spec- 
ulation in mind are now under way in our laboratory to 
reconcile these inconsistent findings. 
In conclusion, we, for the first time, have demonstrated that 
either TIMP-1 or TIMP-2 at the concentration expressing 
growth factor activity induced tyrosine phosphorylation, acti- 
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ated MAP kinase, and stimulated DNA synthesis in the ab- 
sence of other exogenous growth factors. 
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